What are the most effective antibiotics for treating traveler's diarrhea (Gastroenteritis acquired during travel)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Azithromycin should be considered the first-line agent for traveler's diarrhea, particularly in cases of dysentery or acute watery diarrhea with greater than mild fever, due to its efficacy and the increasing resistance of fluoroquinolones. The choice of antibiotic for traveler's diarrhea depends on the severity of the illness, the geographic region, and the likelihood of antibiotic resistance. According to the guidelines for the prevention and treatment of travelers' diarrhea, azithromycin (1000mg single dose or 500mg daily for 3 days) is recommended as the first-line treatment for moderate to severe traveler's diarrhea, especially in areas with high rates of fluoroquinolone resistance, such as Southeast Asia 1.

Some key points to consider when choosing an antibiotic for traveler's diarrhea include:

  • The efficacy of the antibiotic against common bacterial causes of traveler's diarrhea, such as E. coli, Salmonella, Shigella, and Campylobacter
  • The likelihood of antibiotic resistance in the geographic region
  • The safety and tolerability of the antibiotic
  • The simplicity of the treatment regimen and patient adherence

In addition to azithromycin, other antibiotics that may be considered for traveler's diarrhea include fluoroquinolones, such as ciprofloxacin (500mg twice daily for 1-3 days), and rifaximin (200mg three times daily for 3 days), which is a non-absorbable antibiotic that works well for non-invasive diarrhea. However, the use of fluoroquinolones is limited by the increasing resistance of common bacterial causes of traveler's diarrhea, particularly in Southeast Asia 1.

It's also important to note that antibiotics should be reserved for moderate to severe cases of traveler's diarrhea, and that mild cases often resolve on their own within a few days. Travelers should pack these medications before their trip after consulting with their healthcare provider about the best option for their specific destination and medical history. Staying hydrated and considering adding loperamide (Imodium) for symptom relief are also important aspects of managing traveler's diarrhea 1.

From the FDA Drug Label

XIFAXAN is indicated for the treatment of travelers’ diarrhea (TD) caused by noninvasive strains of Escherichia coli in adults and pediatric patients 12 years of age and older XIFAXAN was not found to be effective in patients with diarrhea complicated by fever and/or blood in the stool or diarrhea due to pathogens other than Escherichia coli. The best antibiotic for traveler’s diarrhea is rifaximin (XIFAXAN), but only for cases caused by noninvasive strains of Escherichia coli in adults and pediatric patients 12 years of age and older 2.

  • It is not effective for diarrhea complicated by fever and/or blood in the stool or diarrhea due to pathogens other than Escherichia coli.
  • Alternative antibiotic therapy should be considered if diarrhea symptoms get worse or persist more than 24 to 48 hours 2.
  • Rifaximin (XIFAXAN) should not be used in patients where Campylobacter jejuni, Shigella spp., or Salmonella spp. may be suspected as causative pathogens 2.

From the Research

Best Antibiotics for Traveler's Diarrhea

  • The most effective antibiotics for traveler's diarrhea include azithromycin, fluoroquinolones, and rifaximin 3, 4, 5, 6.
  • Azithromycin is the drug of choice, especially in Asia where Campylobacter is common 3.
  • Fluoroquinolone antibiotics are effective in Latin America and Africa where ETEC is predominant 3.
  • Rifaximin is a suitable option for prevention and treatment of traveler's diarrhea, especially for patients with chronic comorbidities 3, 7, 5.

Treatment Guidelines

  • For mild traveler's diarrhea, the use of antibiotics is not recommended, and bismuth subsalicylate or loperamide may be considered 6.
  • For moderate traveler's diarrhea, antibiotics such as fluoroquinolones, azithromycin, and rifaximin may be used, and loperamide may be considered as monotherapy or adjunctive therapy 6.
  • For severe traveler's diarrhea, antibiotics such as azithromycin, fluoroquinolones, and rifaximin should be used 6.

Considerations for Patients with Chronic Comorbidities

  • Patients with chronic comorbidities, such as diabetes, hypertension, or cardiovascular disease, should be cautious when taking antibiotics for traveler's diarrhea due to potential drug interactions 7.
  • Levofloxacin and rifaximin are considered safe for patients with hypertension, and rifaximin exhibits mild interaction only with metformin 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Azithromycin and loperamide are comparable to levofloxacin and loperamide for the treatment of traveler's diarrhea in United States military personnel in Turkey.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007

Research

Therapy for and prevention of traveler's diarrhea.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007

Research

Travelers' Diarrhea: A Clinical Review.

Recent patents on inflammation & allergy drug discovery, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.